Home/Filings/4/0001493152-23-011747
4//SEC Filing

DST Capital LLC 4

Accession 0001493152-23-011747

CIK 0001563665other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 5:00 PM ET

Size

8.4 KB

Accession

0001493152-23-011747

Insider Transaction Report

Form 4
Period: 2023-04-06
Transactions
  • Purchase

    Common Stock

    2023-04-06$6.00/sh+62,500$375,0003,725,825 total
  • Other

    Warrants (right to buy)

    2023-04-06+110,000140,000 total
    Exercise: $2.00From: 2021-09-01Exp: 2026-09-01Common Stock (110,000 underlying)
Holdings
  • Common Stock

    (indirect: Owned by sole member of reporting person)
    30,722
Footnotes (2)
  • [F1]On March 31, 2023, the Issuer and the Reporting Person entered into a securities purchase agreement pursuant to which on April 6, 2023 the Reporting Person acquired 62,500 shares of the Issuer's common stock, $0.01 par value (the "Shares") from the Issuer in a private placement. The aggregate subscription amount paid by the Reporting Person for the Shares was $375,000.
  • [F2]These warrants were transferred by the Reporting Person to two unaffiliated persons.

Documents

1 file

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727656

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 5:00 PM ET
Size
8.4 KB